Rational design of p53, an intrinsically unstructured protein, for the fabrication of novel molecular sensors

被引:8
|
作者
Geddie, ML [1 ]
O'Loughlin, TL [1 ]
Woods, KK [1 ]
Matsumura, I [1 ]
机构
[1] Emory Univ, Sch Med, Ctr Fundamental & Appl Mol Evolut, Rollins Res Ctr,Dept Biochem, Atlanta, GA 30322 USA
关键词
D O I
10.1074/jbc.M508149200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The dominant paradigm of protein engineering is structure based site-directed mutagenesis. This rational approach is generally more effective for the engineering of local properties, such as substrate specificity, than global ones such as allostery. Previous workers have modified normally unregulated reporter enzymes, including beta-galactosidase, alkaline phosphatase, and beta-lactamase, so that the engineered versions are activated (up to 4-fold) by monoclonal antibodies. A reporter that could easily be "reprogrammed" for the facile detection of novel effectors (binding or modifying activities) would be useful in high throughput screens for directed evolution or drug discovery. Here we describe a straightforward and general solution to this potentially difficult design problem. The transcription factor p53 is normally regulated by a variety of post-translational modifications. The insertion of peptides into intrinsically unstructured domains of p53 generated variants that were activated up to 100-fold by novel effectors (proteases or antibodies). An engineered p53 was incorporated into an existing high throughput screen for the detection of human immunodeficiency virus protease, an arbitrarily chosen novel effector. These results suggest that the molecular recognition properties of intrinsically unstructured proteins are relatively easy to engineer and that the absence of crystal structures should not deter the rational engineering of this class of proteins.
引用
收藏
页码:35641 / 35646
页数:6
相关论文
共 50 条
  • [21] The novel p53 isoform "delta p53" is a misfolded protein and does not bind the p21 promoter site
    Garcia-Alai, Maria M.
    Tidow, Henning
    Natan, Eviatar
    Townsley, Fiona M.
    Veprintsev, Dmitry B.
    Fersht, Alan R.
    PROTEIN SCIENCE, 2008, 17 (10) : 1671 - 1678
  • [22] Design and synthesis of novel p53 inhibitors for neuroprotection.
    Zhu, XX
    Greig, NH
    Mattson, MP
    Culmsee, C
    Yu, QS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U19 - U19
  • [23] The Isoforms of the p53 Protein
    Khoury, Marie P.
    Bourdon, Jean-Christophe
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2010, 2 (03): : a000927
  • [24] p53, a protein with a pulse
    Tanita Casci
    Nature Reviews Genetics, 2004, 5 : 162 - 162
  • [25] p53, a protein with a pulse
    Casci, T
    NATURE REVIEWS GENETICS, 2004, 5 (03) : 162 - 163
  • [26] p53 protein accumulation and p53 gene mutation in esophageal carcinoma - A molecular and immunohistochemical study with clinicopathologic correlations
    Coggi, G
    Bosari, S
    Roncalli, M
    Graziani, D
    Bossi, P
    Viale, G
    Buffa, R
    Ferrero, S
    Piazza, M
    Blandamura, S
    Segalin, A
    Bonavina, L
    Peracchia, A
    CANCER, 1997, 79 (03) : 425 - 432
  • [27] Rational Design of an Orthogonal Molecular Interaction System at the Complex Interface of Lung Cancer-Related MDM2 Protein with p53 Peptide
    Li, Yanwen
    Yu, Xiyan
    Lou, Ying
    Wang, Tong
    AUSTRALIAN JOURNAL OF CHEMISTRY, 2016, 69 (10) : 1167 - 1171
  • [28] Novel protein–protein interactions of TPPII, p53, and SIRT7
    Jarmila Nahálková
    Molecular and Cellular Biochemistry, 2015, 409 : 13 - 22
  • [30] Generation of p53 suppressor peptide from the fragment of p53 protein
    Mittelman, JM
    Gudkov, AV
    SOMATIC CELL AND MOLECULAR GENETICS, 1999, 25 (03) : 115 - 128